Ignite Creation Date:
2024-05-06 @ 9:27 AM
Last Modification Date:
2024-10-26 @ 12:14 PM
Study NCT ID:
NCT02984995
Status:
COMPLETED
Last Update Posted:
2020-02-17
First Post:
2016-12-05
Brief Title:
Phase 2 Study of Quizartinib in Participants With Acute Myeloid Leukemia AML FLT3 Internal Tandem Duplication FLT3ITD Mutation
Sponsor:
Daiichi Sankyo Co Ltd
Organization:
Daiichi Sankyo